Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.

Cochrane database of systematic reviews (Online)

Volumn 5, Issue , 2011, Pages

  Smith, Jonathan M ^a   Steel, David Hw ^b  

^a SUNDERLAND EYE INFIRMARY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY; VASCULOTROPIN; VASCULOTROPIN A;

DIABETIC RETINOPATHY; DRUG ANTAGONISM; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VITRECTOMY; VITREOUS HEMORRHAGE;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; HUMANS; INTRAVITREAL INJECTIONS; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 79959501690     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (0)